Roy A. Whitfield - 16 Sep 2021 Form 4 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
Director
Signature
Mark A. Wilson, Attorney-In-Fact
Issuer symbol
NKTR
Transactions as of
16 Sep 2021
Net transactions value
+$552,000
Form type
4
Filing time
17 Sep 2021, 18:44:04 UTC
Next filing
24 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTR Common Stock Options Exercise $552,000 +40,000 +22% $13.80* 225,850 16 Sep 2021 Direct
holding NKTR Common Stock 51,500 16 Sep 2021 by Whitfield Family 2020 Trust
holding NKTR Common Stock 20,000 16 Sep 2021 by Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTR Stock Option Options Exercise $0 -40,000 -100% $0.000000* 0 16 Sep 2021 Common Stock 40,000 $13.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.